Literature DB >> 7938214

Effectiveness of photofrin II in activation of macrophages and in vitro killing of retinoblastoma cells.

N Yamamoto1, T W Sery, J K Hoober, N P Willett, D D Lindsay.   

Abstract

Administration of a small dose (300 ng/mouse) of photofrin II (PII) to mice, followed by 4 days of exposure to only ambient fluorescent light in animal quarters, induced Fc-receptor-mediated phagocytic and superoxide-generating capacities of peritoneal macrophages by five- and seven-fold, respectively. When these mice were kept in the dark for 4 days, no activation of macrophages was observed. These results suggest that macrophage activation is a consequence of photodynamic activation. Much higher doses (> 3000 ng/mouse) suppressed macrophage activity. However, 2 months after administration of 3000 ng PII/mouse, greatly enhanced phagocytic and superoxide-generating capacities of peritoneal macrophages were observed. In vitro photodynamic activation of macrophages was analyzed after white or red fluorescent light exposure of mouse peritoneal cells (mixture of macrophages and B and T lymphocytes) in media containing PII. A short (10 s) white fluorescent light treatment of peritoneal cells in a medium containing 0.03 ng PII/mL produced the maximal level of phagocytic activity of macrophages. Illumination with the same total fluence of red fluorescent light requires a three-fold higher concentration of PII to achieve the same extent of enhanced phagocytic activity of macrophages. Thus, photodynamic activation of macrophages with PII by white fluorescent light was more efficient than by red fluorescent light. Similarly, photodynamic killing of retinoblastoma cells was more efficient with white than red fluorescent light. The concentration of hematoporphyrin (HP) or PII required for direct photodynamic killing of retinoblastoma cells was roughly four orders of magnitude greater than that required for activation of macrophages.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7938214     DOI: 10.1111/j.1751-1097.1994.tb05084.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  3 in total

1.  Multimodal imaging and photothermal synergistic immunotherapy of retinoblastoma with tuftsin-loaded carbonized MOF nanoparticles.

Authors:  Hongmi Zou; Meng Li; Xing Li; Wendi Zheng; Hongyu Kuang; Menglei Wang; Wenli Zhang; Haitao Ran; Huafeng Ma; Xiyuan Zhou
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

2.  What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity.

Authors:  Chanda Bhandari; Mina Guirguis; N Anna Savan; Navadeep Shrivastava; Sabrina Oliveira; Tayyaba Hasan; Girgis Obaid
Journal:  Nano Today       Date:  2020-12-16       Impact factor: 20.722

3.  Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity.

Authors:  S Coutier; L Bezdetnaya; S Marchal; V Melnikova; I Belitchenko; J L Merlin; F Guillemin
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.